Wang Mao
11Patents
3h-index
44Co-inventors
56Inventor score
Filing activity: Aug 15, 2007 → Oct 15, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8293917B2 | Pyrazole compounds as CCR1 antagonists | Chemistry; Metallurgy | 7 | Active |
| US8093266B2 | Rho kinase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US9975882B2 | Heteroaromatic compounds as BTK inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10875852B2 | Heteroaromatic compounds as BTK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10138229B2 | Heteroaromatic compounds as BTK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10570118B2 | Isoquinolones as BTK inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8318723B2 | Pyrazine compounds, their use and methods of preparation | Chemistry; Metallurgy | 1 | Active |
| US8859814B2 | Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them | Chemistry; Metallurgy | 0 | Active |
| US9828364B2 | Pyrazole compounds as BTK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8895750B2 | Heteroaromatic compounds as BTK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9815822B2 | Heteroaromatic compounds as BTK inhibitors | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.